Waters and BioCity Celebrate New Facility
Waters Corporation and BioCity have celebrated the opening of a new open access analytical laboratory located in the BioHub at Alderley Park, Cheshire, UK.
Waters Corporation (Hertfordshire, UK) and BioCity (Cheshire, UK) have celebrated the opening of a new open access analytical laboratory located in the BioHub at Alderley Park, Cheshire, UK. The institute contains Waters’ liquid chromatography (LC), mass spectrometry (MS), and informatics technologies, within a suite of analytical modules designed for use in the pharmaceutical and life sciences industries.
“At Alderley Park, and indeed across the BioCity group, we are working with a growth formula that provides emerging and growing companies with access to everything they need to succeed – be it people, facilities, finance, or technology,” said Dr. Glenn Crocker (MBE) CEO, BioCity Group. He continued, “We are proud to be playing a leading role at the forefront of both the local and national economy.”
“The companies located at BioHub are engaged in breakthrough research and development. Close engagement with these companies provides Waters with a deeper insight into their needs and challenges,” said Rohit Khanna, Senior Vice President, Applied Technology Group, Waters Corporation.
Chancellor of the Exchequer, George Osborne, also praised the new laboratories, “This is more great news for Alderley Park and for Life Sciences in Cheshire. We are home to so many innovative and growing businesses in the sector and I was delighted to hear that BioCity Group and larger employers like Waters are helping to nurture new talent.”
The laboratory will be resourced with many of Waters’ equipment as well as a nuclear magnetic resonance (NMR) system provided by Manchester Science Partnerships, the owners of Alderley Park.
For more information please visit http://www.biohubatalderley.co.uk/
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
